Pharmaceutical compositions of the invention comprise covalently closed circular DNA formation inhibitors having a disease-modifying action in the treatment of diseases associated with the formation of covalently closed circular DNA that include hepatitis B infection, and any disease involving formation of covalently closed circular DNA.
本发明的药物组合物包括共价闭合环状DNA形成
抑制剂,具有改变疾病的作用,用于治疗与共价闭合环状DNA形成相关的疾病,包括乙型肝炎感染和任何涉及共价闭合环状DNA形成的疾病。